Bristol-Myers Squibb (BMY)

46.98 +1.23 (2.69%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/25/19 *Est.)
- M&A (9/30/19 *Est)

Latest Headlines

Kitov Pharma Announces Significant Progress in Closing of FameWave Acquisition Deal August 16, 2019 8:24 AM - Globe NewsWire Kitov Pharma Announces Significant Progress in Closing of FameWave Acquisition Deal August 16, 2019 8:24 AM - StreetInsider Paulson's 13F Shows New Stakes in Sotheby's (BID), Lyft (LYFT), Increase in Allergan (AGN), Sprint (S) (more...) August 14, 2019 5:10 PM - StreetInsider Elliott Management Enters Marathon Petroleum (MPC) - 13F August 14, 2019 4:22 PM - StreetInsider Administrative Enforcement Agreement Finalized between Kitov Pharma and the Israeli Securities Authority August 14, 2019 8:20 AM - Globe NewsWire Administrative Enforcement Agreement Finalized between Kitov Pharma and the Israeli Securities Authority August 14, 2019 8:20 AM - StreetInsider Atlantic Equities Upgrades Bristol-Myers Squibb Co. (BMY) to Overweight August 14, 2019 4:38 AM - StreetInsider Baupost's 13F Shows New Stake in XPO Logistics (XPO), Increase in Bristol-Myers Squibb (BMY), CBS (CBS), Liquidated Celgene (CELG) (More...) August 13, 2019 5:28 PM - StreetInsider Kitov Pharma Reports First Half 2019 Financial Results and Provides Business Update August 8, 2019 8:20 AM - Globe NewsWire Kitov Pharma Reports First Half 2019 Financial Results and Provides Business Update August 8, 2019 8:20 AM - StreetInsider PTC Therapeutics Expands Presence in New Jersey by Securing State-of-the-Art Biologics Facility August 5, 2019 8:00 AM - PR NewsWire Form 4 BRISTOL MYERS SQUIBB CO For: Jul 31 Filed by: BERTOLINI ROBERT J August 1, 2019 5:07 PM - SEC Filing Nektar (NKTR) and Bristol-Myers Squibb (BMY) Announce FDA Breakthrough Therapy Designation for Bempegaldesleukin with Opdivo for Treatment of Patients with Untreated Advanced Melanoma August 1, 2019 7:59 AM - StreetInsider Nektar Therapeutics and Bristol-Myers Squibb Announce U.S. FDA Breakthrough Therapy Designation for Bempegaldesleukin (NKTR-214) in Combination with Opdivo® (nivolumab) for the Treatment of Patients August 1, 2019 7:00 AM - PR NewsWire Celgene (CELG) Tops Q2 EPS by 23c, Raises Gudiance July 30, 2019 7:35 AM - StreetInsider Celgene Reports Second Quarter 2019 Operating and Financial Results July 30, 2019 7:30 AM - BizWire Cancer drug Keytruda, vaccines propel Merck to quarterly profit beat July 30, 2019 7:13 AM - StreetInsider Bristol-Myers Squibb (BMY) Announces European Commission Approval of Pending Acquisition of Celgene (CELG) July 29, 2019 10:10 AM - StreetInsider Bristol-Myers Squibb Announces European Commission Approval of Pending Acquisition of Celgene July 29, 2019 10:10 AM - BizWire Pfizer to spinoff, merge off-patent drugs unit with Mylan July 29, 2019 7:01 AM - StreetInsider Bristol-Myers Squibb (BMY) Receives Positive CHMP Opinion Recommending Approval of Empliciti Plus Pomalidomide and Low-Dose Dexamethasone for Treatment of Patients with R/R MM July 26, 2019 7:06 AM - StreetInsider Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Empliciti (elotuzumab) Plus Pomalidomide and Low-Dose Dexamethasone for Treatment of Patients with Relapsed and Refractory July 26, 2019 6:59 AM - BizWire Active options: INTC BA F MSFT AMD TWTR T NVDA MU AMZN BMY DIS July 26, 2019 4:32 AM - StreetInsider Form 10-Q BRISTOL MYERS SQUIBB CO For: Jun 30 July 25, 2019 11:35 AM - SEC Filing Eliquis, Orencia sales propel Bristol-Myers to strong second quarter July 25, 2019 10:35 AM - StreetInsider Pre-Open Movers 07/25: (DBD) (NTGR) (MTH) Higher; (ALGN) (SAVE) (PTC) (more...) July 25, 2019 9:16 AM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: Jul 25 July 25, 2019 8:21 AM - SEC Filing Bristol-Myers Squibb (BMY) Tops Q2 EPS by 12c, Raises FY Guidance July 25, 2019 7:02 AM - StreetInsider Bristol-Myers Squibb Reports Second Quarter Financial Results July 25, 2019 6:59 AM - BizWire Options expected to have increasing volume: BMY PYPL ALGN BUD July 25, 2019 4:36 AM - StreetInsider After-Hours Movers 07/24: (NTGR) (AINK) (MTH) Higher; (ALGN) (SAVE) (TSLA) (more...) July 24, 2019 6:02 PM - StreetInsider Bristol-Myers Squibb (BMY) Shares Decline After Part 2 of Phase 3 CheckMate -227 Did Not Meet Primary Endpoint July 24, 2019 4:55 PM - StreetInsider Bristol-Myers Squibb (BMY) Part 2 of the Phase 3 CheckMate -227 Did Not Meet Primary Endpoint July 24, 2019 4:49 PM - StreetInsider Bristol-Myers Squibb (BMY) Part 1 of Phase 3 CheckMate -227 Trial Met Primary Endpoint July 24, 2019 4:48 PM - StreetInsider Bristol-Myers Squibb Announces CheckMate -227 Part 1a Meets Co-Primary Endpoint of Overall Survival July 24, 2019 4:16 PM - BizWire Bristol-Myers Squibb Provides Update on Part 2 of CheckMate -227 July 24, 2019 4:16 PM - BizWire Bristol-Myers Squibb (BMY), Bayer & Ono Pharma Report Collaboration Agreement to Investigate Stivarga (regorafenib) & Opdivo (nivolumab) as Combination Therapy July 18, 2019 6:35 AM - StreetInsider Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement to investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as combination therapy in patients wit July 18, 2019 6:32 AM - PR NewsWire Bayer, Bristol-Myers Squibb and Ono Pharmaceutical Enter Into a Clinical Collaboration Agreement to Investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as Combination Therapy in Patients Wit July 18, 2019 6:30 AM - BizWire Bristol-Myers Squibb (BMY) July option implied volatility low July 8, 2019 5:48 AM - StreetInsider Form 4 BRISTOL MYERS SQUIBB CO For: Jul 01 Filed by: Santiago Karen Murphy July 3, 2019 1:36 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Jul 01 Filed by: Hirawat Samit July 3, 2019 1:36 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: Vousden Karen H July 2, 2019 5:21 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: Storch Gerald L July 2, 2019 5:21 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: Paliwal Dinesh C July 2, 2019 5:20 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: Samuels Theodore R. II July 2, 2019 5:20 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: LACY ALAN J July 2, 2019 5:20 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: GROBSTEIN MICHAEL July 2, 2019 5:19 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: Emmens Matthew July 2, 2019 5:19 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: BERTOLINI ROBERT J July 2, 2019 5:18 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: Arduini Peter J July 2, 2019 5:18 PM - SEC Filing Form 3 BRISTOL MYERS SQUIBB CO For: Jun 28 Filed by: Hirawat Samit July 1, 2019 5:23 PM - SEC Filing Form 8-K BRISTOL MYERS SQUIBB CO For: Jul 01 July 1, 2019 7:00 AM - SEC Filing Bristol-Myers Squibb Completes Divestment of UPSA July 1, 2019 5:17 AM - BizWire Form 8-K BRISTOL MYERS SQUIBB CO For: Jun 28 June 28, 2019 8:00 AM - SEC Filing Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes June 28, 2019 6:59 AM - BizWire Kitov Pharma (KTOV) Reports Complete Lab Phase of IND-Enabling Studies for NT219 June 27, 2019 7:37 AM - StreetInsider Kitov Successfully Completes IND-enabling Studies to advance NT219 for the Treatment of Patients with Recurrent or Metastatic Head and Neck Cancers June 27, 2019 7:31 AM - StreetInsider Kitov Successfully Completes IND-enabling Studies to advance NT219 for the Treatment of Patients with Recurrent or Metastatic Head and Neck Cancers June 27, 2019 7:30 AM - Globe NewsWire Bristol-Myers Squibb Co. (BMY) PT Cut To $66 At Societe Generale On Otezla Divestment June 27, 2019 6:52 AM - StreetInsider Popular stocks with increasing unusual volume: WDC ABBV BMY BYND June 27, 2019 4:38 AM - StreetInsider Bristol-Myers Squibb (BMY) Trades at Low, Down 2.2% June 26, 2019 2:47 PM - StreetInsider UPDATE: Pfizer (PFE) Hits Low as Shares of Large Pharma Names Tank June 26, 2019 2:46 PM - StreetInsider Eli Lilly & Co. (LLY) Trades Near Low, Down 3.7% Amid Biotech Selloff June 26, 2019 12:06 PM - StreetInsider Popular stocks with increasing unusual volume: SHOP DBXMRK CGC MSFT BMY CZR LYB CELG June 24, 2019 10:47 AM - StreetInsider Spark Therapeutics (ONCE) Trades Lower in Sympathy with Celgene (CELG) June 24, 2019 10:35 AM - StreetInsider Pre-Open Movers 06/24: (PCMI) (NERV) (PTN) (DFRG) (CZR) (ERI) (BMY) (CELG) (SPOT) (more) June 24, 2019 8:57 AM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: Jun 24 June 24, 2019 8:02 AM - SEC Filing Bristol-Myers Squibb (BMY) is Planning Divestiture of OTEZLA to Get FTC Clearance for Celgene (CELG) Deal June 24, 2019 7:02 AM - StreetInsider Bristol-Myers Squibb (BMY) CheckMate -459 Study Evaluating Opdivo as First-Line Treatment for Patients with Unresectable HCC Did Not Meet Primary Endpoint June 24, 2019 7:00 AM - StreetInsider Bristol-Myers Squibb Announces Results from CheckMate -459 Study Evaluating Opdivo (nivolumab) as a First-Line Treatment for Patients with Unresectable Hepatocellular Carcinoma June 24, 2019 6:59 AM - BizWire Bristol-Myers Squibb Provides Update on Pending Merger with Celgene June 24, 2019 6:59 AM - BizWire Form 3 BRISTOL MYERS SQUIBB CO For: Jun 12 Filed by: Eid Joseph June 20, 2019 5:08 PM - SEC Filing Catalent (CTLT) Reports Acquisition of Bristol-Myers Squibb (BMY) Manufacturing Facility in Anagni, Italy June 19, 2019 7:01 AM - StreetInsider Catalent to Purchase Bristol-Myers Squibb Manufacturing Facility in Anagni, Italy June 19, 2019 6:59 AM - BizWire Catalent to Purchase Bristol-Myers Squibb Manufacturing Facility in Anagni, Italy June 19, 2019 6:59 AM - BizWire Bristol-Myers Squibb Co. (BMY) Estimate Raised At Cowen June 17, 2019 7:19 AM - StreetInsider Bristol-Myers Squibb Presents Updated Efficacy Data from Phase 2 Trial of Empliciti (elotuzumab) Plus Pomalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) June 14, 2019 6:59 AM - BizWire Bristol-Myers Squibb Announces Dividend June 13, 2019 4:38 PM - BizWire New Mechanistic Study Explores the Relationship Between a Key Genetic Marker and Clinical Efficacy of ORENCIA® (abatacept) or adalimumab in Moderate-to-Severe Early Rheumatoid Arthritis Patients June 13, 2019 4:30 PM - BizWire Form 11-K BRISTOL MYERS SQUIBB CO For: Dec 31 June 13, 2019 11:59 AM - SEC Filing Form 11-K BRISTOL MYERS SQUIBB CO For: Dec 31 June 13, 2019 11:56 AM - SEC Filing Form 11-K BRISTOL MYERS SQUIBB CO For: Dec 31 June 13, 2019 11:52 AM - SEC Filing Bristol-Myers Squibb Co. (BMY) PT Lowered to $51 at UBS June 13, 2019 6:27 AM - StreetInsider Form 4 BRISTOL MYERS SQUIBB CO For: Jun 10 Filed by: Powell Ann June 12, 2019 4:40 PM - SEC Filing Bristol-Myers Squibb to Announce Results for Second Quarter 2019 on July 25, 2019 June 6, 2019 6:59 AM - BizWire Form 8-K BRISTOL MYERS SQUIBB CO For: Jun 05 June 5, 2019 8:25 AM - SEC Filing Bristol-Myers Squibb (BMY) Announces Leadership Team Upon Completion of Pending Merger with Celgene (CELG) June 5, 2019 7:02 AM - StreetInsider Bristol-Myers Squibb Announces Post-Closing Leadership Team June 5, 2019 6:59 AM - BizWire Bristol-Myers Squibb to Take Part in Goldman Sachs 40th Annual Global Healthcare Conference June 4, 2019 12:23 PM - BizWire Bristol-Myers Squibb (BMY) Announces Five-Year Survival Observed in Longest Follow-up to Date of Advanced Melanoma Patients Treated with Opdivo and Yervoy June 3, 2019 2:16 PM - StreetInsider Five-Year Survival Observed in Longest Follow-up to Date of Advanced Melanoma Patients Treated with the Combination of Opdivo (nivolumab) and Yervoy (ipilimumab) June 3, 2019 2:15 PM - BizWire Heat Biologics (HTBX) Reports Promising Interim Phase 2 Lung Cancer Data Investigating HS-110 in Combination with Nivolumab (Opdivo) June 3, 2019 7:16 AM - StreetInsider Bristol-Myers Squibb (BMY) Announces First Presentation of Results for Opdivo Plus Yervoy Combination in Advanced HCC at ASCO June 3, 2019 7:03 AM - StreetInsider Bristol-Myers Squibb Announces First Presentation of Results for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Combination in Advanced Hepatocellular Carcinoma at ASCO 2019 June 3, 2019 6:59 AM - BizWire Form 8-K BRISTOL MYERS SQUIBB CO For: May 29 May 30, 2019 4:42 PM - SEC Filing Goldman Sachs Starts Bristol-Myers Squibb Co. (BMY) at Buy May 28, 2019 2:39 AM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: May 24 May 24, 2019 8:07 AM - SEC Filing Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes May 24, 2019 6:59 AM - BizWire Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors - Corrected Version May 21, 2019 7:54 AM - StreetInsider Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors - Corrected Version May 21, 2019 7:52 AM - Globe NewsWire Form 4 BRISTOL MYERS SQUIBB CO For: May 16 Filed by: Santiago Karen Murphy May 20, 2019 4:38 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: May 16 Filed by: Samuels Theodore R. II May 20, 2019 4:38 PM - SEC Filing Dr. Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors May 20, 2019 7:54 AM - StreetInsider Dr. Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors May 20, 2019 7:52 AM - Globe NewsWire Argus Downgrades Bristol-Myers Squibb Co. (BMY) to Hold May 20, 2019 7:27 AM - StreetInsider Full Article List